The AstraZeneca vaccine got a bad rap in the United States. Here's a case from a few months ago that it deserves greater appreciation, especially for averting deaths in poorer countries where it's used primarily for first doses rather than boosters.
The triumph of the Oxford-AstraZeneca vaccine
Despite setbacks, the jab has probably saved more lives than any other
economist.com